79 related articles for article (PubMed ID: 19684847)
1. Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.
Güler S; Sharma SK; Almustafa M; Kim CH; Azar S; Danciulescu R; Shestakova M; Khutsoane D; Bech OM
Arch Drug Inf; 2009 Jun; 2(2):23-33. PubMed ID: 19684847
[TBL] [Abstract][Full Text] [Related]
2. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
3. Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus.
Lalić NM; Micić D; Antić S; Bajović L; Pantelinac P; Jotić A; Kendereski A; Dimić D; Djukić A; Mitrović M; Vujasin M
Expert Opin Pharmacother; 2007 Dec; 8(17):2895-901. PubMed ID: 18001251
[TBL] [Abstract][Full Text] [Related]
4. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
Gao Y; Guo XH; Vaz JA;
Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
[TBL] [Abstract][Full Text] [Related]
5. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
[TBL] [Abstract][Full Text] [Related]
6. Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT.
Strojek K; Bebakar WM; Khutsoane DT; Pesic M; Smahelová A; Thomsen HF; Kalra S
Curr Med Res Opin; 2009 Dec; 25(12):2887-94. PubMed ID: 19821654
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study.
Esteghamati A; Rajabian R; Amini M; Bahrami A; Khamseh ME; Afkhami-Ardekani M; Rizi EP
Endokrynol Pol; 2010; 61(4):364-70. PubMed ID: 20806180
[TBL] [Abstract][Full Text] [Related]
8. Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.
Gough SC; Tibaldi J
Clin Drug Investig; 2007; 27(5):299-324. PubMed ID: 17451279
[TBL] [Abstract][Full Text] [Related]
9. Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study.
Shestakova M; Sharma SK; Almustafa M; Min KW; Ayad N; Azar ST; Danciulescu R; Khutsoane D; Guler S
Curr Med Res Opin; 2007 Dec; 23(12):3209-14. PubMed ID: 18005503
[TBL] [Abstract][Full Text] [Related]
10. Basal insulin or premix analogue therapy in type 2 diabetes patients.
Raskin PR; Hollander PA; Lewin A; Gabbay RA; Bode B; Garber AJ;
Eur J Intern Med; 2007 Jan; 18(1):56-62. PubMed ID: 17223044
[TBL] [Abstract][Full Text] [Related]
11. Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study.
Yang W; Gao Y; Liu G; Chen L; Fu Z; Zou D; Feng P; Zhao Z
Curr Med Res Opin; 2010 Jan; 26(1):101-7. PubMed ID: 19916705
[TBL] [Abstract][Full Text] [Related]
12. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
[TBL] [Abstract][Full Text] [Related]
14. An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.
Dashora U; Ashwell SG; Home PD
Diabetes Obes Metab; 2009 Jul; 11(7):680-7. PubMed ID: 19527481
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
[TBL] [Abstract][Full Text] [Related]
16. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with BIAsp 30: Results from the Bangladesh cohort of the global A1chieve study.
Latif ZA; Pathan MF; Mannan MA; Siddiqui MN; Ashrafuzzaman SM; Rahman MM; Sobhan MJ
Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):93-8. PubMed ID: 26118154
[TBL] [Abstract][Full Text] [Related]
18. Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.
McSorley PT; Bell PM; Jacobsen LV; Kristensen A; Lindholm A
Clin Ther; 2002 Apr; 24(4):530-9. PubMed ID: 12017398
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thrice daily 'high' vs. 'medium' premixed insulin aspart with respect to evening and overnight glycaemic control in patients with type 2 diabetes.
Ejskjaer N; Rasmussen M; Kamp N; Lindholm A; Christiansen JS
Diabetes Obes Metab; 2003 Nov; 5(6):438-45. PubMed ID: 14617230
[TBL] [Abstract][Full Text] [Related]
20. [Comparison on the efficacy of biphasic insulin aspart 30 and premixed human insulin 30/70 through continuous glucose monitoring system].
Chen SF; Li H
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Aug; 32(8):827-9. PubMed ID: 22093477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
